October 19, 2022
Open to all ISPOR Members and Non-members
Wednesday, October 19, 2022
Title: Can the Benefits From Biosimilars Be Sustainably Increased? Policy Recommendations for Europe, Middle East and Canada
9:00AM EDT | 1:00PM UTC | 3:00PM CEST
Biosimilars offer great potential for the patients, payers and the whole society. However, there exist policy barriers which can hinder this potential. The debate will analyze the challenges and opportunities for biosimilars uptake in Europe, Middle East and Canada.
Steven Simoens, MSc, PhD, Professor of Health Economics, KU Leuven, Leuven, Belgium
John Esdaile, MD, MPH, FRCPC, FCAHS, MACR, Professor, University of British Columbia and University of Calgary, Canada
Francesco Saverio Mennini, Aggregate Professor, Tor Vergata, University of Rome, Rome, Italy
Khalid Alnaqbi, Chair of the Emirati Board of Rheumatology, National Institute for Health Specialties, Abu Dhabi, United Arab Emirates
Javier Bécares, Head of Service, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Beatriz Ardizone Jiménez, MSc, Associate Pharmacist, Hospital University Rey Juan Carlos, Madrid, Spain
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.